Interplay of nuclear factor-κB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor α

Molecular Endocrinology

Volumn 22, Issue 2, 2008, Pages 273-286

  Ko, Soyoung ^a   Shi, Liheng ^a,c   Kim, Soyoung ^a   Song, Chung S ^a   Chatterjee, Bandana ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; HISTONE DEACETYLASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN B MYB; PROTEIN P50; REGULATOR PROTEIN; RETINOID; SCAFFOLD PROTEIN; SYNAPTOTAGMIN I; THYROID HORMONE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CHROMATIN; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; UNTRANSLATED REGION;

ADENOVIRIDAE; ANDROGENS; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU NICK-END LABELING; MALE; MODELS, BIOLOGICAL; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECOMBINANT PROTEINS; RESPONSE ELEMENTS; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38749094419     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0332     Document Type: Article

References (40)

1. Tomlins SA, Rhodes DR, Perner D, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM 2005 Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644-648
2. Litvinov IV, Griend DJ, Antony L, Dalrymple S, Demarzo AM, Drake CG, Isaacs JT 2006 Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells. Proc Natl Acad Sci USA 103:15085-15090
3. Gioeli D 2005 Signal transduction in prostate cancer progression. Clin Sci 108:293-308
4. Palvimo JJ, Reinikainen P, Ikonen T, Kallio PJ, Moilanen A, Janne OA 1996 Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem 271:24151-24156
5. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG, Sawyers CL 2004 Molecular determinants of resistance to antiandrogen therapy. Nat Med 10:33-39
6. Grad JM, Dai JL, Wu S, Burnstein KL 1999 Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA. Mol Endocrinol 13:1896-1911
7. Eder IE, Culig Z, Ramoner R, Thurnher M, Putz T, Messler-Menardi C, Tiefenthaler M, Barsch G, Klocker H 2000 Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Cancer Gene Ther 7:997-1007
8. Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ 2002 Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 62:1008-1013
9. Liao X, Tang S, Thrasher JB, Griebling TL, Li B 2005 Small interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol Cancer Ther 4:505-515
10. Zou JX, Zhong Z, Shi XB, Tepper CG, DeVere White RW, Kung HJ, Chen H 2006 ACTR/AIBI/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. Prostate 66:1474-1486
11. Linja MJ, Savinainen KJ, Saramäki OR, Tammela TLJ, Vessella RL, Visakorpi T 2001 Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 61:3550-3555
12. Ford III O, Gregory CW, Kim D, Smitherman AB, Mohler JL 2003 Androgen receptor gene amplification and protein expression in recurrent prostate cancer. J Urol 170:1817-1821
13. Mantovani A 2005 Inflammation by remote control. Nature 435:752-753
14. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG 2007 Inflammation in prostate carcinogenesis. Nat Rev Cancer 7:256-269
15. Zhu P, Baek SH, Bourk EM, Ohgi KA, G-Bassets I, Sanjo H, Akira S, Kotol PF, Glass CK, Rosenfeld MG, Rose DW 2006 Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 124:615-629
16. Hayden MS, Ghosh S 2004 Signaling to NF-κB. Genes Dev 18:2195-2224
17. Supakar PC, Jung MH, Song CS, Chatterjee B, Roy AK 1995 Nuclear factor κB functions as a negative regulator for the rat androgen receptor gene and NF-κB activity increases during the age-dependent desensitization of the liver. J Biol Chem 270:837-842
18. Zerbini LF, Wang Y, Czibere A, Correa RG, Cho J, Ijiri K, Wei W, Joseph M, Gu X, Grall F, Goldring MB, Zhou, J-R, Libermann TA 2004 NF-κB mediated repression of growth arrest- and DNA-damage-inducible proteins 45α and γ is essential for cancer cell survival. Proc Natl Acad Sci USA 101:13618-13623
19. Sitcheran R, Gupta P, Fisher PB, Baldwin AS 2005 Positive and negative regulation of EAAT2 by NF-κB: a role for N-myc in TNF-α controlled repression. EMBO J 24:510-520
20. Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E, Greene WC 2006 NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 25:139-149
21. Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T 2000 Tumor necrosis factor-α represses androgen sensitivity in the LNCaP prostate cancer cell line. J Urol 164:800-805
22. Wang C-Y, Mayo MW, Baldwin AS 1996 TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274:784-787
23. Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S, Chung LW 1994 Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer 57:406-412
24. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang S, Ozen M, Pathak S, Chung LWK 2000 LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 44:91-103
25. Chopra DP, Menard RE, Januszewski J, Mattingly RR 2004 TNF-α-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines. Cancer Lett 203:145-154
26. Lin D, Fiscella M, O'Connor PM, Jackman J, Chen M, Luo LL, Sala A, Travali S, Appella E, Mercer WE 1994 Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest. Proc Natl Acad Sci USA 91:10079-10083
27. Cervellera M, Raschella G, Santilli G, Tanno B, Ventura A, Mancini, C, Sevignani C, Calabretta B, Sala A 2000 Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB. J Biol Chem 275:21055-21060
28. Miyake H, Hara I, Kamidono S, Gleave ME, Ito H 2003 Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression. Oncol Rep 10:469-473
29. Ashburner BP, Westerheide SD, Baldwin AS 2001 The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21:7065-7077
30. Chen JD, Evans RM 1995 A transcriptional corepressor that interacts with nuclear hormone receptors. Nature 377:454-457
31. Ogawa S, Lozach J, Jepsen K, Sawka-Verhelle D, Perissi V, Sasik R, Rose, DW, Johnson RS, Rosenfeld MG, Glass CK 2004 A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation. Proc Natl Acad Sci USA 101:14461-14466
32. Knoepfler PS, Eisenman RN 1999 Sin meets NuRD and other tails of repression. Cell 9:447-450
33. Alland L, Muhle R, Hou H, Potes J, Chin L, Schreiber-Agus N, Depinho RA 1997 Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55
34. Heinzel T, Lavinsky RM, Mullen T-M, Söderström M, Laherty CD, Torchia J, Yang W-M, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG 1997 A complex containing NCoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48
35. Wang LG, Ossowski L, Ferrari AC 2001 Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. Cancer Res 61:7544-7551
36. Wang LG, Ferrari AC 2006 Mithramycin targets Sp1 and the androgen receptor transcription level - potential therapeutic role in advanced prostate cancer. Translational Oncogenomics 2:19-31
37. Tran TT, Segev DL, Gupta V, Kawakubo H, Yeo G, Donahoe PK, Maheswaran S 2006 Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-κB-dependent Smad-independent mechanism. Mol Endocrinol 20:2382-2391
38. Song CS, Echchgadda I, Seo Y-K, Kim S, Kim S-A, Cho S, Shi L, Chatterjee B 2006 An essential role of the CAAT/enhancer binding protein-α in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1). Mol Endocrinol 20:795-808
39. Chatterjee B, Echchgadda I, Song S 2005 Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1. "Phage II: conjugation enzymes, glutathione transferases and transportsystems." Methods Enzymol 400:165-191
40. Dignam JD, Lebowitz RM, Roeder RG 1983 Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489